Purchases and Sales Made in Q3 2024 in Hcw Biologics Inc. (HCWB)
This table provides information about the institutional ownership of Hcw Biologics Inc. (HCWB) during Q3 2024. The information is specifically focused on institutions that hold shares of HCW Biologics Inc..
Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
---|---|---|---|---|---|---|---|
Nov 12, 2024
Q3 2024
|
Geode Capital Management, LLC
Boston, MA |
BUY
|
- |
12.9K+ 7.56% |
$5.41K - $9.01K
|
183K
$75.1K
|
|
Nov 14, 2024
Q3 2024
|
Ubs Group Ag
|
BUY
|
- |
546+ 12.74% |
$229 - $382
|
4.83K
$1.98K
|
|
Nov 14, 2024
Q3 2024
|
Bank Of America Corp
Charlotte, NC |
BUY
|
- |
183+ 117.31% |
$76.9 - $128
|
339
$139
|
|
Oct 10, 2024
Q3 2024
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
Nov 14, 2024
Q3 2024
|
Two Sigma Investments, LP
New York, NY |
SELL
|
- |
-37- 0.16% |
$15.5 - $25.9
|
22.4K
$9.2K
|
|
Nov 14, 2024
Q3 2024
|
Tower Research Capital LLC (Trc)
New York, NY |
SELL
|
- |
-331- 5.33% |
$139 - $232
|
5.88K
$2.41K
|
|
Oct 24, 2024
Q3 2024
|
Pullen Investment Management, LLC
Bradenton, FL |
SELL
|
- |
-10K- 11.75% |
$4.2K - $7K
|
75.1K
$30.8K
|
|
Nov 12, 2024
Q3 2024
|
Hrt Financial LP
New York, NY |
SELL
|
- |
-20.2K- 30.25% |
$8.47K - $14.1K
|
46.5K
$19.1K
|